BlossomHill Therapeutics, Inc. Stock Performance
as on September 19, 2026 at 5:08 am IST
Day's Low
Day's High
$25.55$27.55
2.41%
Downside
5.23%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
BlossomHill Therapeutics, Inc. share price movements today
- Previous Close
- $26.82
- Open
- $27.55
- Volume
- 177.2K
- Market Cap
- $763.4M
- Day's Low - High
- $25.55 - $27.55
BlossomHill Therapeutics, Inc. Historical Returns
- 1 Month Return
- + 66.58 %
- 3 Month Return
- 0 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
BlossomHill Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check BlossomHill Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$763.4M
EPS (TTM)
-0.72
Dividend Yield
0.00%
PE Ratio (TTM)
-24.83
Industry PE ratio
0.00
PEG Ratio
-0.24833333333333332
Return On Equity TTM
20.70%
BlossomHill Therapeutics, Inc. Stock Valuation
Track how BlossomHill Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
BlossomHill Therapeutics, Inc. in the last 2 years
Lowest (-15.09x)
December 31, 2024
Industry (0.00x)
December 31, 2025
Today (-7.69x)
December 31, 2025
Highest (-7.69x)
December 31, 2025
Today’s Price to Earnings Ratio: -7.69x
BlossomHill Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of BlossomHill Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $763.4M | NA | -24.83 | 0.00% | 0.00% | |
| BUY | $42.2B | 530.61% | -22.23 | 0.00% | 0.00% | |
| BUY | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| BUY | $63.1B | -63.24% | -19.81 | -12.57% | 0.00% | |
| BUY | $79.7B | 21.1% | 18.48 | 84.86% | 0.48% |
Analyst Recommendation on BlossomHill Therapeutics, Inc. Stock
Based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for BlossomHill Therapeutics, Inc.. Average target price of $31.25
Indian Investors' Interest in BlossomHill Therapeutics, Inc. Stock
Search interest for BlossomHill Therapeutics, Inc. Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:36% versus previous 30 day period
BlossomHill Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
BlossomHill Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
BlossomHill Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
BlossomHill Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
BlossomHill Therapeutics, Inc. News & Key Events
Insights on BlossomHill Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, BLSM stock has moved up by 28.6%
About BlossomHill Therapeutics, Inc.
| Organisation | BlossomHill Therapeutics, Inc. |
| Headquarters | 10255 Science Center Drive, San Diego, CA, United States, 92121 |
| Industry | Biotechnology |
| CEO | Dr. Jingrong Jean Cui Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of BlossomHill Therapeutics, Inc.
Name | Title |
|---|---|
Dr. Eugene Y. Rui Ph.D. | Senior Vice President of Chemistry |
Dr. Antonio Garrido-Montalban Ph.D. | Senior Vice President of Drug Substance |
Mr. Jason A. Keyes M.B.A. | CFO & Executive VP |
Dr. Geoff Oxnard M.D. | Chief Medical Officer & Executive VP |
Dr. Vincent Liptak J.D., M.B.A., Ph.D. | General Counsel & Executive VP |
Dr. Zachary F. Zimmerman M.D., Ph.D. | Senior Vice President of Clinical Development |
Dr. Z. Jesse Shao Ph.D., R.Ph. | Senior Vice President of CMC |
Dr. Ashley Preston Ph.D. | Senior VP and Head of Regulatory Affairs & Quality Assurance |
Dr. Yishan Li M.B.A., Ph.D. | Co-Founder & Executive Chairman |
Dr. Jingrong Jean Cui Ph.D. | Scientific Founder, President, CEO & Director |
FAQs
What is BlossomHill Therapeutics, Inc. share price today?
BlossomHill Therapeutics, Inc. share price today is $26.18 as on . BlossomHill Therapeutics, Inc. share today touched a day high of $27.55 and a low of $25.55.
What is the 52 week high and 52 week low for BlossomHill Therapeutics, Inc. share?
BlossomHill Therapeutics, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . BlossomHill Therapeutics, Inc. stock price today i.e. is trending at $26.18,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is BlossomHill Therapeutics, Inc.'s market capitalisation today?
BlossomHill Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in BlossomHill Therapeutics, Inc. Stock (BLSM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for BlossomHill Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BlossomHill Therapeutics, Inc. Shares that will get you 0.0573 shares as per BlossomHill Therapeutics, Inc. share price of $26.18 per share as on September 18, 2026 at 11:38 pm IST.
What is the minimum amount required to buy BlossomHill Therapeutics, Inc. Stock (BLSM) from India?
Indian investors can start investing in BlossomHill Therapeutics, Inc. (BLSM) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in BlossomHill Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on BlossomHill Therapeutics, Inc. share’s latest price of $26.18 as on September 18, 2026 at 11:38 pm IST, you will get 0.3820 shares of BlossomHill Therapeutics, Inc.. Learn more about
fractional shares .